• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.

作者信息

Antonioli E, Guglielmelli P, Pancrazzi A, Bogani C, Verrucci M, Ponziani V, Longo G, Bosi A, Vannucchi A M

出版信息

Leukemia. 2005 Oct;19(10):1847-9. doi: 10.1038/sj.leu.2403902.

DOI:10.1038/sj.leu.2403902
PMID:16079890
Abstract
摘要

相似文献

1
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.JAK2 V617F突变在原发性血小板增多症中的临床意义
Leukemia. 2005 Oct;19(10):1847-9. doi: 10.1038/sj.leu.2403902.
2
Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.无V617F JAK2突变的原发性血小板增多症是克隆性造血干细胞疾病。
Leukemia. 2006 Jun;20(6):1181-3. doi: 10.1038/sj.leu.2404214.
3
The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia.JAK2 V617F突变的存在与真性红细胞增多症中较高的血红蛋白水平及血栓形成风险增加相关。
Br J Haematol. 2006 Jan;132(2):244-5. doi: 10.1111/j.1365-2141.2005.05858.x.
4
Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood.真性红细胞增多症中粒细胞JAK2 V617F突变的遗传异质性：对外周血中突变检测的意义
Pathology. 2006 Aug;38(4):336-42. doi: 10.1080/00313020600820906.
5
The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS).伴有环形铁粒幼细胞的难治性贫血（RARS）患者亚组中的JAK2-V617F突变及真性红细胞增多症特征
Blood. 2006 Sep 1;108(5):1781-2. doi: 10.1182/blood-2006-03-008227.
6
JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.原发性血小板增多症中的JAK2突变：临床关联及长期预后相关性
Br J Haematol. 2005 Oct;131(2):208-13. doi: 10.1111/j.1365-2141.2005.05764.x.
7
JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients.
Leukemia. 2006 Oct;20(10):1903-5. doi: 10.1038/sj.leu.2404341. Epub 2006 Aug 3.
8
JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status.原发性血小板增多症患者血小板中的JAK2V617F突变：与临床特征的相关性及STAT5磷酸化状态分析
Eur J Haematol. 2006 Sep;77(3):210-6. doi: 10.1111/j.1600-0609.2006.00688.x.
9
Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.聚乙二醇化干扰素α-2b治疗真性红细胞增多症和原发性血小板增多症后对JAK2突变状态的影响有限。
Haematologica. 2006 Sep;91(9):1281-2.
10
Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.散发性原发性血小板增多症患儿JAK2 V617F突变的频率及临床特征
Pediatr Blood Cancer. 2008 Dec;51(6):802-5. doi: 10.1002/pbc.21730.

引用本文的文献

1
The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.沙特阿拉伯的一项研究：骨髓增殖性疾病患者中 Janus 激酶 2 与凝血因子 V 莱顿突变及血栓形成并发症之间的关联
Cureus. 2024 Nov 25;16(11):e74401. doi: 10.7759/cureus.74401. eCollection 2024 Nov.
2
Relation of V617F allele burden and coronary calcium score in patients with essential thrombocythemia.原发性血小板增多症患者 V617F 等位基因负担与冠状动脉钙评分的关系。
Radiol Oncol. 2024 Oct 4;58(4):565-572. doi: 10.2478/raon-2024-0036. eCollection 2024 Dec 1.
3
Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.
费城染色体阴性骨髓增殖性肿瘤：从造血干细胞到临床特征的分子历程
Medicina (Kaunas). 2021 Sep 30;57(10):1043. doi: 10.3390/medicina57101043.
4
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia.IRF4 和 IRF8 的表达与原发性血小板增多症的临床表型和临床血液学对羟基脲的反应相关。
Front Med. 2022 Jun;16(3):403-415. doi: 10.1007/s11684-021-0858-1. Epub 2021 Jul 31.
5
Retrospective analysis of the clinical features of 172 patients with -negative chronic myeloproliferative neoplasms.172例阴性慢性骨髓增殖性肿瘤患者临床特征的回顾性分析。
Mol Cytogenet. 2020 Feb 17;13:8. doi: 10.1186/s13039-020-0471-z. eCollection 2020.
6
JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.JAK2及其他：克什米尔人群骨髓增殖性疾病和血液系统恶性肿瘤中JAK2V617的突变研究
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3611-3615. doi: 10.31557/APJCP.2019.20.12.3611.
7
A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence.一例原发性血小板增多症合并IgA肾病病例及相关并发情况的文献综述
Case Rep Oncol Med. 2019 Sep 2;2019:5086963. doi: 10.1155/2019/5086963. eCollection 2019.
8
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.骨髓增殖性肿瘤指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2019年
Hematol Transfus Cell Ther. 2019 Jul;41 Suppl 1(Suppl 1):1-73. doi: 10.1016/j.htct.2019.03.001. Epub 2019 May 10.
9
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.用于快速鉴定JAK2 V617F错义突变的高分辨率熔解分析检测方法的开发及其验证。
Exp Hematol Oncol. 2019 Apr 30;8:10. doi: 10.1186/s40164-019-0134-0. eCollection 2019.
10
Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.费城阴性经典骨髓增殖性肿瘤中的血栓形成：流行病学、风险评估和病理生理机制的叙述性综述。
J Thromb Thrombolysis. 2018 May;45(4):516-528. doi: 10.1007/s11239-018-1623-4.